MXC

MGC Pharma Rebrands as Argent BioPharma in Strategic Transformation

Retrieved on: 
Tuesday, February 13, 2024

LONDON, Feb. 13, 2024 /PRNewswire/ -- MGC Pharmaceuticals Ltd (LSE: MXC), (OTC: MGCLF), (ASX: MXC)  Rebrands as Argent BioPharma in Strategic TransformationMarking a significant milestone in its evolutionary journey, MGC Pharma has officially announced its rebranding to Argent BioPharma, pending approval from its shareholders. This rebranding is the culmination of an extensive restructuring, incorporating significant American capital and operational revisions. Poised for growth, Argent BioPharma is now set to emerge as a key player in the biopharmaceutical industry, leveraging cutting-edge advancements in Polypharmacology and Nanotechnology. With its presence on both the London Stock Exchange and the Australian Stock Exchange, Argent BioPharma is well-positioned to make substantial contributions to enhancing medical treatment accessibility.

Key Points: 
  • LONDON, Feb. 13, 2024 /PRNewswire/ -- MGC Pharmaceuticals Ltd (LSE: MXC), (OTC: MGCLF), (ASX: MXC)  Rebrands as Argent BioPharma in Strategic Transformation
    Marking a significant milestone in its evolutionary journey, MGC Pharma has officially announced its rebranding to Argent BioPharma, pending approval from its shareholders.
  • Poised for growth, Argent BioPharma is now set to emerge as a key player in the biopharmaceutical industry, leveraging cutting-edge advancements in Polypharmacology and Nanotechnology.
  • With its presence on both the London Stock Exchange and the Australian Stock Exchange, Argent BioPharma is well-positioned to make substantial contributions to enhancing medical treatment accessibility.
  • As Argent BioPharma transitions from MGC Pharma, it stands ready to lead a new era in biopharmaceuticals, promising accessible and impactful healthcare solutions on a global scale.

Mexco Energy Corporation Reports Financial Results for Third Quarter

Retrieved on: 
Friday, February 9, 2024

Operating revenues in the third quarter of fiscal 2024 were $1,656,443.

Key Points: 
  • Operating revenues in the third quarter of fiscal 2024 were $1,656,443.
  • For more information on Mexco Energy Corporation, go to www.mexcoenergy.com .
  • Mexco Energy Corporation disclaims any intention or obligation to revise any forward-looking statements.
  • For additional information, please contact: Tammy L. McComic, President and Chief Financial Officer, at Mexco Energy Corporation, (432) 682-1119.

Rigetti Launches the Novera QPU, the Company’s First Commercially Available QPU

Retrieved on: 
Wednesday, December 6, 2023

The Novera QPU is manufactured in Rigetti’s Fab-1, the industry’s first dedicated and integrated quantum device manufacturing facility.

Key Points: 
  • The Novera QPU is manufactured in Rigetti’s Fab-1, the industry’s first dedicated and integrated quantum device manufacturing facility.
  • The Novera QPU includes all of the hardware below the mixing chamber plate (MXC) of a dilution refrigerator.
  • The Novera QPU is designed to be integrated with commercially available dilution refrigerators and control systems.
  • The Novera QPU is available to order at rigetti.com/novera starting at $900,000 and ships within 4-6 weeks after the order is confirmed and shipping and logistics are finalized.

Mexco Energy Corporation Reports Financial Results for Six Months

Retrieved on: 
Wednesday, November 8, 2023

Operating revenues in the first six months of fiscal 2024 decreased 34% to $3,155,029.

Key Points: 
  • Operating revenues in the first six months of fiscal 2024 decreased 34% to $3,155,029.
  • For more information on Mexco Energy Corporation, go to www.mexcoenergy.com .
  • Mexco Energy Corporation disclaims any intention or obligation to revise any forward-looking statements.
  • For additional information, please contact: Tammy L. McComic, President and Chief Financial Officer of Mexco Energy Corporation, (432) 682-1119.

XConn Technologies Showcases Composable Memory System Prototype with CXL™ 2.0 Ecosystem at 2023 OCP Global Summit

Retrieved on: 
Tuesday, October 17, 2023

SAN JOSE, Calif., Oct. 17, 2023 /PRNewswire/ -- XConn Technologies (XConn), the innovation leader in next-generation interconnect technology for the future of high-performance computing and AI applications, today announced that it will be displaying a Composable Memory System prototype during the 2023 OCP Global Summit, October 17-19 in San Jose, at the OCP Open Experience Center. The demonstration – which will include solutions from AMD, Intel, MemVerge, Montage, SMART Modular and XConn's Apollo CXL/PCIe switch – will highlight the benefits of a Compute Express Link™ (CXL™) 2.0-based Composable Memory System featuring memory expansion, pooling, and sharing for demanding HPC and AI applications.

Key Points: 
  • SAN JOSE, Calif., Oct. 17, 2023 /PRNewswire/ -- XConn Technologies (XConn), the innovation leader in next-generation interconnect technology for the future of high-performance computing and AI applications, today announced that it will be displaying a Composable Memory System prototype during the 2023 OCP Global Summit, October 17-19 in San Jose, at the OCP Open Experience Center.
  • The Composable Memory System (CMS) is a sub-project within the OCP.
  • Its mission is to define architecture and the spec for memory systems that are composable to meet the demand of AI computing.
  • During OCP Global Summit, XConn will demonstrate a first-in-class composable memory system with servers powered by AMD, Intel, the Memory eXpander Controller (MXC) for CXL from Montage Technology, elastic memory software from MemVerge, and the high-speed CPU interconnect (CMM) for CXL from SMART Modular Technologies.

XConn Technologies is First to Demonstrate a CXL 2.0 Switch with Future Intel Xeon Processors and Ecosystem

Retrieved on: 
Tuesday, September 19, 2023

SAN JOSE, Calif., Sept. 19, 2023 /PRNewswire/ -- XConn Technologies (XConn), the innovation leader in next-generation interconnect technology for the future of high-performance computing and AI applications, today announced that it will be the first to demonstrate the complete Compute Express Link™ (CXL™) 2.0 ecosystem, from end-to-end. The demonstration, to be featured at Intel Innovation, September 19-20 in San Jose Convention Center, booth 229, will showcase, for the first time, the CXL 2.0 specification in action, from host to device, for the ability to scale up to 15 TB to support "Just a Bunch of Memory" (JBOM) applications needed by HPC and AI environments.

Key Points: 
  • The XConn Apollo Switch which supports CXL 2.0 interoperates with Samsung DRAM Memory Expander supporting CXL, Micron CZ120 memory expansion module, Memory eXpander Controller (MXC) for CXL from Montage Technology, and the high-speed CPU interconnect (CMM) for CXL from Smart Modular Technologies.
  • The Apollo switch is the industry's first and only hybrid CXL 2.0 and PCIe Gen 5 interconnect solution.
  • "Micron and XConn have been expanding the relevance of the XConn CXL 2.0 switch features to emerging applications," said Siva Makineni, vice president of Micron's Advanced Memory Systems.
  • "We're pleased to see XConn bring together a complete ecosystem of CXL 2.0 innovators to illustrate the value of CXL for the future of processing," said Larrie Carr, president, CXL Consortium.

Montage's MXC Chip Passes CXL1.1 Compliance Test by CXL Consortium

Retrieved on: 
Monday, August 21, 2023

SHANGHAI, Aug. 21, 2023 /PRNewswire/ -- Montage Technology recently achieved a significant milestone with its CXL Memory eXpander Controller (MXC), which successfully passed the rigorous CXL 1.1 compliance testing sponsored by the CXL Consortium.

Key Points: 
  • SHANGHAI, Aug. 21, 2023 /PRNewswire/ -- Montage Technology recently achieved a significant milestone with its CXL Memory eXpander Controller (MXC), which successfully passed the rigorous CXL 1.1 compliance testing sponsored by the CXL Consortium.
  • The CXL Consortium's compliance testing holds paramount importance in verifying the adherence of diverse devices within the CXL ecosystem, including CPUs, CXL-based devices, and accelerators, to the stringent CXL specifications.
  • Montage's trailblazing journey began in May 2022 when it introduced the world's first CXL™ Memory eXpander Controller (MXC).
  • The inclusion of MXC on the CXL website, side by side with other CXL-compliant offerings from prominent CPU and memory manufacturers, demonstrates the industry's recognition of Montage's pioneering CXL technology.

Mexco Energy Corporation Reports Financial Results for First Quarter

Retrieved on: 
Thursday, August 10, 2023

Operating revenues in the first quarter of fiscal 2024 were $1,748,419, a decrease of 29% from the first quarter of fiscal 2023.

Key Points: 
  • Operating revenues in the first quarter of fiscal 2024 were $1,748,419, a decrease of 29% from the first quarter of fiscal 2023.
  • For more information on Mexco Energy Corporation, go to www.mexcoenergy.com .
  • Mexco Energy Corporation disclaims any intention or obligation to revise any forward-looking statements.
  • For additional information, please contact: Tammy L. McComic, President and Chief Financial Officer of Mexco Energy Corporation, (432) 682-1119.

MEXCO ENERGY CORPORATION REPORTS FINANCIAL RESULTS FOR FISCAL 2023

Retrieved on: 
Monday, June 26, 2023

MIDLAND, TX, June 26, 2023 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE American: MXC) reported results on its Annual Report, Form 10-K to the Securities and Exchange Commission for the fiscal year ended March 31, 2023.

Key Points: 
  • MIDLAND, TX, June 26, 2023 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE American: MXC) reported results on its Annual Report, Form 10-K to the Securities and Exchange Commission for the fiscal year ended March 31, 2023.
  • Operating revenues in fiscal 2023 were $9,557,289, an increase of 45% when compared to fiscal 2022 operating revenues of $6,587,780.
  • Approximately 28% of the fiscal 2023 revenues were produced from royalties free of operational costs to Mexco.
  • For additional information, please contact: Tammy L. McComic, President and Chief Financial Officer of Mexco Energy Corporation, (432) 682-1119.

Historic Milestone: UK Patients Receive First CannEpil® Delivery through 'I AM Billy Foundation' and GMC Specialist Register

Retrieved on: 
Wednesday, May 31, 2023

LONDON, May 31, 2023 /PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC), (ASX: MXC), (OTC: MGCLF), a leading European pharmaceutical firm specializing in plant-derived medications, announced today that its ground-breaking Investigational Medicinal Product (IMP), CannEpil®, has been successfully imported and received by its first patients in the United Kingdom.

Key Points: 
  • It is part of MGC's rigorous clinical development programme for patients suffering from refractory epilepsy, also known as drug-resistant epilepsy.
  • The initiative permits clinicians listed on The General Medical Council (GMC) specialist register to prescribe CannEpil®.
  • The delivery also supports the RESCAS study, a research initiative aiming to address the substantial unmet medical need of refractory epilepsy.
  • CannEpil® was supplied to the 'I AM Billy Foundation' through the NHS's Refractory Epilepsy Specialist Clinical Advisory Service, the only route in the UK for patients to receive public funding for cannabis-based treatments of refractory epilepsy.